Literature DB >> 22534680

[Castleman's disease : a rare differential diagnosis for Heerfordt's syndrome].

R Hirt1, U Krause, S Knipping.   

Abstract

A 50-year-old male patient demonstrated an existing left proptosis for several weeks. The patient was suffering from physical exhaustion and had lost considerable weight. Furthermore, we observed greatly enlarged parotid and submandibular glands on both sides. MRI of the neck showed multiple, sharply circumscribed lesions in the major salivary glands and both lacrimal glands as well as in the orbit. Initially we suspected Heerfordt's syndrome, a manifestation of sarcoidosis, but laboratory diagnosis could not reveal a pathological erythrocyte sedimentation rate or an increased ACE titer. After exploratory excision from the right submandibular gland, histological examination revealed Castleman's disease. Therefore, we initiated an immunomodulatory therapy with interleukin-6 receptor antagonists.Castleman's disease is one of the very rare, benign, lymphoproliferative processes that have a tendency to turn malignant. Isolated findings of Castleman's disease should be completely resected. There are no clear treatment strategies for multiple localizations of Castleman's disease. The approaches range from systemic glucocorticoid therapy with chemotherapy to immunomodulatory treatment. In contrast to isolated findings, the prognosis for multicentric occurrence is unfavorable.

Entities:  

Mesh:

Year:  2012        PMID: 22534680     DOI: 10.1007/s00106-012-2522-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  9 in total

1.  [Castleman tumor as a rare differential diagnosis of cervical space-occupying lesion].

Authors:  A Rübberdt; M Memming; J Brennecke; J Jähne
Journal:  Chirurg       Date:  2001-08       Impact factor: 0.955

2.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

3.  Unifocal cervical Castleman disease in two children.

Authors:  D Tuerlinckx; E Bodart; M Delos; M Remacle; J Ninane
Journal:  Eur J Pediatr       Date:  1997-09       Impact factor: 3.183

4.  Castleman's disease as a uncommon cause of a neck mass.

Authors:  D P Kooper; R M Tiwari; P van der Valk
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

Authors:  G M Chronowski; C S Ha; R B Wilder; F Cabanillas; J Manning; J D Cox
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

6.  [Heerfordt's syndrome -- a rare initial manifestation of sarcoidosis].

Authors:  C Walter; A Schwarting; T Hansen; G Weibrich
Journal:  Mund Kiefer Gesichtschir       Date:  2005-01

Review 7.  [Castleman's disease in ear, nose, and throat practice].

Authors:  A Schrock; I Gutgemann; S Keiner
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

8.  Report of a case of localized Castleman's disease with progression to malignant lymphoma.

Authors:  M Vasef; W E Katzin; G Mendelsohn; M Reydman
Journal:  Am J Clin Pathol       Date:  1992-12       Impact factor: 2.493

9.  [Castleman's disease].

Authors:  F Hölzle; A Landers; C Platz-Baudin; D Basrei; K-D Wolff
Journal:  Mund Kiefer Gesichtschir       Date:  2005-03
  9 in total
  3 in total

Review 1.  Rare Diseases of the Oral Cavity, Neck, and Pharynx.

Authors:  Christoph A Reichel
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

2.  Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.

Authors:  Hiroki Mochizuki; Manako Kato; Takakazu Higuchi; Ryosuke Koyamada; Satoru Arai; Sadamu Okada; Hikaru Eto
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

3.  Castleman's Disease Presenting as a Parotid Mass in the Pediatric Population: A Report of 2 Cases.

Authors:  Sean W Delaney; Shengmei Zhou; Dennis Maceri
Journal:  Case Rep Otolaryngol       Date:  2015-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.